Old Web
English
Sign In
Acemap
>
authorDetail
>
R. Hooijmaijers
R. Hooijmaijers
Protease
NS3
Medicine
Virology
Diabetes mellitus
2
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
458 FINAL RESULTS OF THE PHARMACOKINETICS, EFFICACY, AND SAFETY/TOLERABILITY OF 400 AND 600 MG ONCE-DAILY DOSING OF ACH-1625 (HCV NS3 PROTEASE INHIBITOR) IN HCV GENOTYPE 1
2011
Journal of Hepatology
V. Detishin
W. Haazen
R. Hooijmaijers
M. Ruppert
K. Bol
H. Robison
L. Robarge
Atul Agarwal
Milind Deshpande
E. Olek
Show All
Source
Cite
Save
Citations (6)
855 ONCE-DAILY REGIMENS OF THE HCV NS3/4A-PROTEASE INHIBITOR TMC435350 ARE PREDICTED TO PROVIDE THERAPEUTIC EXPOSURE IN PLASMA AND LIVER
2008
Journal of Hepatology
G.A.E. van t Klooster
I. Vanwelkenhuysen
R. Hooijmaijers
K. Bol
Marieke Christiane Johanna Voets
J. Van Houdt
R. Verloes
Fatima Aharchi
K. Marien
P. Van Remoortere
F. Broeckaert
H. de Kock
K. Simmen
Show All
Source
Cite
Save
Citations (7)
1